World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
21767
World Ranking
2647
National Ranking
104

Overview

William Vermi is affiliated with the University of Brescia in Italy. Their research centers primarily on immunology and microbiology, with significant work also conducted in the fields of medicine and oncology.

Their published research spans several key topics including:

  • Immune cells in cancer
  • Immune cell function and interaction
  • Cancer immunotherapy and biomarkers
  • Immunotherapy and immune responses
  • T-cell and B-cell immunology
  • Immune response and inflammation
  • Neutrophil, myeloperoxidase and oxidative mechanisms

Frequent co-authors collaborating with William Vermi include:

  • Mattia Bugatti
  • Silvia Lonardi
  • Matilde Monti
  • Francesco Missale
  • Marco A. Cassatella

They have contributed multiple papers to publication venues such as:

  • Frontiers in Immunology
  • Cancers
  • Zenodo (CERN European Organization for Nuclear Research)
  • Nature Communications
  • Cancer Immunology Research

Examples of recent papers authored or co-authored by William Vermi include:

  • "TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy," 2020, Cell
  • "Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer," 2022, Cell
  • "Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth," 2020, Nature Microbiology
  • "Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy," 2020, International Journal of Molecular Sciences
  • "Single-cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions," 2021, Nature Communications

William Vermi's research contributions reflect a focus on understanding the cellular and molecular mechanisms underlying immune responses, particularly in cancer and inflammatory diseases. The work involves analysis of tumor microenvironments, immune cell heterogeneity, and the interactions between immune cells and cancer therapies.

Best Publications

  • Adaptive immunity maintains occult cancer in an equilibrium state

    Catherine M. Koebel;William Vermi;William Vermi;Jeremy B. Swann;Jeremy B. Swann;Nadeen Zerafa

  • A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

    Marina Cella;Anja Fuchs;William Vermi;Fabio Facchetti

  • IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

    Yaming Wang;Kristy J Szretter;William Vermi;William Vermi;Susan Gilfillan

  • Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12- and IL-15-Responsive IFN-γ-Producing Cells

    Anja Fuchs;William Vermi;William Vermi;Jacob S. Lee;Silvia Lonardi

  • BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction

    Andrzej Dzionek;Yoshiaki Sohma;Jun Nagafune;Marina Cella

  • TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy

    Martina Molgora;Ekaterina Esaulova;William Vermi;Jinchao Hou

  • Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer

    Unknown

  • Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual.

    Melissa Swiecki;Susan Gilfillan;William Vermi;Yaming Wang

  • Cancer immunoediting by the innate immune system in the absence of adaptive immunity

    Timothy O’Sullivan;Robert Saddawi-Konefka;William Vermi;Catherine M. Koebel

  • Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin

    William Vermi;Elena Riboldi;Valerie Wittamer;Francesca Gentili

  • Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

    Mirna Balsamo;Francesca Scordamaglia;Gabriella Pietra;Claudia Manzini

  • Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas.

    William Vermi;Raffaella Bonecchi;Fabio Facchetti;Denise Bianchi

  • Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin.

    Karel Otero;Isaiah R Turnbull;Pietro Luigi Poliani;William Vermi

  • Mature CD10+ and immature CD10− neutrophils present in G-CSF–treated donors display opposite effects on T cells

    Olivia Marini;Sara Costa;Dalila Bevilacqua;Federica Calzetti

  • BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.

    Marta Cigognetti;Silvia Lonardi;Simona Fisogni;Piera Balzarini

  • Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model

    Sarah L. Rowland;Jeffrey M. Riggs;Susan Gilfillan;Mattia Bugatti

  • A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC.

    Kent S. Boles;William Vermi;Fabio Facchetti;Anja Fuchs

  • Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.

    Alexander D. Barrow;Melissa A. Edeling;Vladimir Trifonov;Jingqin Luo

  • Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells

    Stephen McCartney;William Vermi;Susan Gilfillan;Marina Cella

  • Plasmacytoid dendritic cells prime IFN‐γ‐secreting melanoma‐specific CD8 lymphocytes and are found in primary melanoma lesions

    Mariolina Salio;Marina Cella;William Vermi;Fabio Facchetti

  • Abstract 526: Cancer immunoediting by the innate immune system in the absence of adaptive immunity

    Jack Bui;Timothy O'Sullivan;Robert Saddawi-Konefka;William Vermi

Frequent Co-Authors

Fabio Facchetti
Fabio Facchetti University of Brescia
Silvano Sozzani
Silvano Sozzani Sapienza University of Rome
Marco Colonna
Marco Colonna Washington University in St. Louis
Marco A. Cassatella
Marco A. Cassatella University of Verona
Raffaele Badolato
Raffaele Badolato University of Brescia
Marina Cella
Marina Cella Washington University in St. Louis
Alberto Mantovani
Alberto Mantovani Humanitas University
Robert D. Schreiber
Robert D. Schreiber Washington University in St. Louis
Susan Gilfillan
Susan Gilfillan Washington University in St. Louis
Luigi D. Notarangelo
Luigi D. Notarangelo National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of online degree programs that complement this field. For those interested in clinical applications, accelerated pathways like the accelerated FNP program provide an efficient route to becoming a Family Nurse Practitioner, blending advanced immunological knowledge with patient care.

Individuals without a nursing background can pursue online degrees tailored to their needs, such as the online ABSN programs for non nurses. These programs facilitate a swift transition into nursing, which is useful for those aiming to integrate immunology into healthcare practice.

For students looking for less competitive entry points, considering the easiest accelerated nursing programs can be a practical option. These programs balance quality education with accessibility, enabling quicker entry into the healthcare workforce.

Additionally, pursuing foundational credentials through accredited LPN programs easy to get into offers a solid start for those aiming to build a career in immunology-related nursing roles. These programs provide essential skills that support further specialization and career advancement.

Best Scientists Citing William Vermi

Trending Scientists

Recently Published Articles